The effect of rituximab in desensitization of preoperative DSA positive patients and postoperative ABMR treatment of DSA positive patients in kidney transplantatio
Not Applicable
Recruiting
- Conditions
- Chronic renal failure
- Registration Number
- JPRN-UMIN000035338
- Lead Sponsor
- iigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion Criteria: Patients with cardiac, pulmonary and hepaic dysfunction and severe bone marrow suppression must be excluded. Hypersensitivity history against rituximab and/or boron, who cannot receive informed consent are also excluded. Patients whomDoctor in charge decided inadequate for participate in this study are excluded. Criteria in which study must be stopped: If the participant would expressed refusal against the study. If the study must be stopped due to the severe adveresed event and/or other reaseons for contraindication for treatment and/or kidney transplantation. If this study itself must be stopped according to the certain reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method